<DOC>
	<DOCNO>NCT01225952</DOCNO>
	<brief_summary>The objective study compare contrast sensitivity , high low contrast visual acuity ( VA ) , glare meter outcome , subject satisfaction three different FDA-approved intraocular lens ( IOLs ) design improve distance , intermediate , near vision follow lens extraction adult least 40 year age .</brief_summary>
	<brief_title>Three Intraocular Lenses Designed Improve Distance , Intermediate Near Vision Following Lens Extraction</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Myopia</mesh_term>
	<criteria>Subjects must undergo primary IOL implantation correction aphakia follow continuous curvilinear anterior capsulotomy phacoemulsification cataract extraction . Subjects must require spherical lens power 10.00 diopter ( D ) 33.00 D. Subjects must potential corrected distance visual acuity ( CDVA ) 20/32 good eye . Subjects must stop contact lens wear least two week soft lens wearer three week gas permeable lens wearer prior biometry surgery . At time surgery , subject must intact centered capsulorhexis , intact posterior capsule , zonular rupture . Subjects must â‰¤ 1.25 D preoperative corneal astigmatism eye . Subjects diagnose degenerative visual disorder ( eg , macular degeneration , retinal disorder ) cause potential acuity loss level 20/32 bad . Subjects condition increase risk zonular rupture , pseudoexfoliation syndrome . Subjects active inflammation edema ( swell ) cornea , include limited following : keratitis , keratoconjunctivitis , keratouveitis . Subjects uncontrolled glaucoma . Subjects previous retinal detachment . Subjects visually significant diabetic retinopathy ( proliferative nonproliferative ) reduce potential acuity 20/32 worse . Subjects rubella , bilateral congenital , traumatic , complicate polar cataract . Subjects mark microphthalmos aniridia . Subjects previous corneal surgery . Subjects irregular corneal astigmatism . Subjects amblyopia reduces potential acuity 20/32 worse . Subjects optic atrophy . Subjects iris neovascularization . Subjects clinically significant retinal pigment epithelium/macular change reduce potential acuity 20/32 worse . Subjects chronic use systemic steroid immunosuppressive medication .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>phacoemulsification</keyword>
	<keyword>intraocular lens</keyword>
</DOC>